Literature DB >> 20499004

[Chronic kidney diseases: common and harmful, but also preventable and treatable].

Marcus Gomes Bastos1, Rachel Bregman, Gianna Mastroianni Kirsztajn.   

Abstract

Chronic kidney disease (CKD) is a public health problem worldwide. In Brazil incidence and prevalence of end stage renal failure are increasing; prognosis is still poor and costs of disease treatment are very high. Regardless of the etiology, main outcomes in patients with CKD are its complications (anemia, metabolic acidosis, malnutrition and alteration in mineral metabolism), death (mainly due to cardiovascular causes) and loss of renal function. Recent studies indicate that these outcomes may be postponed with specific treatment if the CKD is diagnosed early and renoprotective and cardioprotective measures are implemented early in the course of the disease. The current definition and staging of CKD, as well as the discussion of the main preventive measures are addressed in this review.

Entities:  

Mesh:

Year:  2010        PMID: 20499004     DOI: 10.1590/s0104-42302010000200028

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  7 in total

1.  Estimating the concentration of urea and creatinine in the human serum of normal and dialysis patients through Raman spectroscopy.

Authors:  Maurício Liberal de Almeida; Cassiano Junior Saatkamp; Adriana Barrinha Fernandes; Antonio Luiz Barbosa Pinheiro; Landulfo Silveira
Journal:  Lasers Med Sci       Date:  2016-07-08       Impact factor: 3.161

2.  Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.

Authors:  Caroline Pereira Domingueti; Luci Maria S Dusse; Rodrigo Bastos Fóscolo; Janice Sepúlveda Reis; Joyce Maria Annichino-Bizzacchi; Fernanda Loureiro de Andrade Orsi; Bruna de Moraes Mazetto; Maria das Graças Carvalho; Karina Braga Gomes; Ana Paula Fernandes
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

3.  Prevalence of clinically validated primary causes of end-stage renal disease (ESRD) in a State Capital in Northeastern Brazil.

Authors:  Luana Rodrigues Sarmento; Paula Frassinetti Castelo Branco Camurça Fernandes; Marcelo Ximenes Pontes; Daniel Barros Santos Correia; Victhor Castelo Branco Chaves; Cecília Ferreira de Araújo Carvalho; Tiago Lima Arnaud; Matheus Henrique Seixas Dos Santos; Livia Cristina Barros Barreto; Larissa Alves Alexandre Moliterno
Journal:  J Bras Nefrol       Date:  2018-05-17

4.  Use of non-invasive intracranial pressure pulse waveform to monitor patients with End-Stage Renal Disease (ESRD).

Authors:  Cristiane Rickli; Lais Daiene Cosmoski; Fábio André Dos Santos; Gustavo Henrique Frigieri; Nicollas Nunes Rabelo; Adriana Menegat Schuinski; Sérgio Mascarenhas; José Carlos Rebuglio Vellosa
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

5.  Anemia in Patients with Type 2 Diabetes Mellitus.

Authors:  Jéssica Barbieri; Paula Caitano Fontela; Eliane Roseli Winkelmann; Carine Eloise Prestes Zimmermann; Yana Picinin Sandri; Emanelle Kerber Viera Mallet; Matias Nunes Frizzo
Journal:  Anemia       Date:  2015-11-11

6.  Comparison between two physiotherapy protocols for patients with chronic kidney disease on dialysis.

Authors:  José Roberto Sostena Neto; Letícia Magalhães Figueiredo E Castro; Fernanda Santos de Oliveira; Andréia Maria Silva; Luciana Maria Dos Reis; Ana Paula Assunção Quirino; Desanka Dragosavac; Carolina Kosour
Journal:  J Phys Ther Sci       Date:  2016-05-31

7.  In vitro studies of the antibacterial activity of Copaifera spp. oleoresins, sodium hypochlorite, and peracetic acid against clinical and environmental isolates recovered from a hemodialysis unit.

Authors:  Rosimara Gonçalves Leite Vieira; Thaís da Silva Moraes; Larissa de Oliveira Silva; Thamires Chiquini Bianchi; Rodrigo Cassio Sola Veneziani; Sérgio Ricardo Ambrósio; Jairo Kenupp Bastos; Regina Helena Pires; Carlos Henrique Gomes Martins
Journal:  Antimicrob Resist Infect Control       Date:  2018-01-24       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.